The Canvys Healthcare team has launched its new Image Systems 6MP (megapixel) display with LED backlights, and the quality control (QC) Vue browser-based, zero-footprint QC tool for mobile devices and displays. The new 30-inch widescreen, color display features LED backlights that provide high brightness and contrast.


The results of the first (of three planned) annual low-dose computed tomography (LDCT) lung cancer screening examinations from the National Lung Screening Trial (NLST) were recently published in the New England Journal of Medicine.

Sensus Healthcare has received clearance from the U.S. Food and Drug Administration (FDA) to treat Keloids with the SRT-100. The SRT-100 is an alternative to surgery in treating non-melanoma skin cancer and now is approved to treat keloids caused by surgery or injury. Leading dermatologists and oncologists have found the SRT-100 superficial radiotherapy system to be a choice for their patients who are not good surgical candidates.  Sensus Healthcare has reintroduced superficial radiotherapy (SRT) to the global clinical community as a viable, safe, and cost-effective modality to treat non-melanoma skin cancers and keloids in hospitals and private practice settings.

Varian Medical Systems received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Varian’s diagnostic X-ray image processing workstation that combines radiographic/fluoroscopy (RF) and digital radiography (DR) capabilities on one platform.  Varian’s Nexus DRF Digital X-Ray Imaging System has the ability to interface with a variety of image receptors, including CCD cameras and commercially available flat-panel image detectors. 

Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue of the journal Radiology. 

Syntermed Inc. has been awarded 510(k) clearance for Emory Cardiac Toolbox version 4.0. "One of the many things that makes Emory Toolbox 4.0 different is SmartReport, the first-ever, cloud-based nuclear cardiology reporting tool using decision support,” said Michael Lee, CEO, Syntermed Inc. The decision support system that powers SmartReport is called Syntermed IDS and will allow diagnosticians to perform faster, more accurate nuclear cardiology reports from single photon emission computed tomography (SPECT) and positron emission tomography (PET) heart scans.


Intermountain Healthcare, a Utah-based nonprofit system of 22 hospitals and 185 clinics, is compiling the cumulative radiation patients receive from about 220,000 higher-dose procedures and imaging exams each year, starting with exams performed in the last quarter of 2012. That information is now readily available to both physicians and patients.

Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found. [1]
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now